Searched for
CIPLA ARM
Stocks in news: Airtel, Tata Motors, Dr Reddy's, NTPC, Dixon TechnologiesMarkets faced selling pressure on Tuesday due to weak global cues and macroeconomic concerns, with the Nifty approaching support at 23,150....- Stocks in news: Cipla, PC Jeweller, Shriram Finance, Grasim, Gland PharmaCipla said it has received the nod from Central Drugs Standard Control Organisation (CDSCO) for the exclusive distribution and marketing of...
- Stocks in news: Jio Financial, Paytm, Axis Bank, Torrent Power, Asian PaintsJio Financial has been added to BSE Allcap and LargeMidcap indices in a major rejig. The changes will be effective from March 18.
- Stocks in news: Titan, Marico, Bajaj Auto, Adani Wilmar, Tata SteelConsumer discretionary major Titan Co saw 22% revenue growth for the third quarter ended December. The growth was broad-based as most of th...
- Cipla gains as arm to buy 40% stake in Cipla Pharma LankaThe stock moved 1.81 per cent higher to trade at Rs 476.50 on the NSE.
- Cipla arm secures marketing rights for cancer drug in USCipla USA, Inc, a subsidiary of the company will be marketing the drug in strengths of 150 and 500 mg tablets.
- Cipla divests 16.7 per cent stake in Chase Pharma to AllerganChase was recently financed by a Series B consortium consisting of New Rhein Healthcare, Edmond de Rothschild Investment Partners and Cipla...
- Cipla gets USFDA nod for generic anti-depressant drugThe company's tablets are generic versions of Valeant's Wellbutrin XL tablets in the same strengths, Cipla said.
- Cipla completes share allocation to FIL Capital InvestmentsCipla today said its arm Cipla Health has completed allocation of shares to FIL Capital Investments II Ltd. It inked an investment agreemen...
- Cipla completes stake sale in Biomab HoldingDrug major Cipla today announced completion of selling its entire holding in Hong Kong-based Biomab Holding to Biomab Brilliant for $ 2.5 m...
- Cipla to sell entire stake in Biomab Holding for $25,775,000Drug major Cipla has entered into an agreement to sell its entire stake in Biomab Holding to Biomab Brilliant for a consideration of $25,77...
- Cipla ties up with Serum Institute to sell vaccines in South AfricaCipla said it had agreed to an exclusive deal with Serum Institute to supply vaccines to South Africa, adding a new market to their partner...
- Hamsons buys 21% stake in Okasa PharmceuticalsWhile Cipla paid Rs 29 crore for Okasa’s facility in Goa, it bought another plant, owned by Okasa Pharma, located in Satara for Rs 71.93 cr...
- Hamied family company buys out minority shareholders in OkasaThe acquisition is part of a two-way transaction under which the Yusuf Khwaja Hamied-run Cipla's wholly-owned arm Medispray Laboratories co...
- Cipla's arm Meditab sells stake in Jiangsu for $ 18.5 millionShares of Cipla were today trading at Rs 648 per scrip in the afternoon trade on the BSE, up 1.27 per cent from its previous clsoe.
- Cipla, BioQuiddity ink pact to sell pain management productCipla intends to launch the CE marked OneDose ReadyfusOR pre-filled with Ropivacaine under its own label into the German market late this y...
- Cipla-Medpro is a marketing tie-up, don’t own any stake in them: S Radhakrishnan, CiplaCipla is a major source of supply for Cipla Medpro South Africa. So that trend will continue and a significant portion of this order, says ...
- Ex-Teva Frank Pieters to lead Cipla's European respiratory businessCipla, India's second-largest drug maker, has hired Teva's former vice-president Frank Pieters to spearhead its European respiratory busine...
- Cipla looks to acquire 25% stake in South African coCipla said it could take a decision to buy stake of up to 25 per cent in South Africa-based, Cipla Medpro in next board meeting. Cipla Medp...
- Cipla under MRTPC scanner for HIV drug 'overpricing'MRTPC has directed its investigative arm to probe the alleged overpricing of HIV drug 'Viraday' by Cipla.
Load More
